Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Mazhgan Rowneki's publication output changed over time?
ScholarIQpublication output · 2017–2024
Output grew0% over the shown period — from 1 works in 2017 to 1 in 2024.
1
1
3
4
1
20172019202220232024
What are the most-cited papers on Mazhgan Rowneki?
ScholarIQmost cited works
Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes
Kristina L. Bajema, Kristin Berry, Elani Streja, Nallakkandi Rajeevan, Yuli Li, Pradeep Mutalik, Lei Yan, Francesca Cunningham, Denise M. Hynes, Mazhgan Rowneki, Amy S. B. Bohnert, Edward J. Boyko, Theodore J. Iwashyna, Matthew L. Maciejewski, Thomas F. Osborne, Elizabeth M. Viglianti, Mihaela Aslan, Grant D. Huang, George N. Ioannou
Annals of Internal Medicine. 202399 CitationsOPEN ACCESS
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes
Kristina L. Bajema, Kristin Berry, Elani Streja, Nallakkandi Rajeevan, Yuli Li, Lei Yan, Francesca Cunningham, Denise M. Hynes, Mazhgan Rowneki, Amy S. B. Bohnert, Edward J. Boyko, Theodore J. Iwashyna, Matthew L. Maciejewski, Thomas F. Osborne, Elizabeth M. Viglianti, Mihaela Aslan, Grant D. Huang, George N. Ioannou
medRxiv. 202256 CitationsOPEN ACCESS
Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era
George N. Ioannou, Amy S. B. Bohnert, Ann M. O’Hare, Edward J. Boyko, Matthew L. Maciejewski, Valerie A. Smith, C. Barrett Bowling, Elizabeth M. Viglianti, Theodore J. Iwashyna, Denise M. Hynes, Kristin Berry, Pamela Green, Alexandra Fox, Anna Korpak, Troy A. Shahoumian, Alex Hickok, Mazhgan Rowneki, Xiao Qing Wang, Emily R. Locke
Annals of Internal Medicine. 202250 CitationsOPEN ACCESS
Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans
George N. Ioannou, Kristin Berry, Nallakkandi Rajeevan, Yuli Li, Pradeep Mutalik, Lei Yan, David Bui, Francesca Cunningham, Denise M. Hynes, Mazhgan Rowneki, Amy S. B. Bohnert, Edward J. Boyko, Theodore J. Iwashyna, Matthew L. Maciejewski, Thomas F. Osborne, Elizabeth M. Viglianti, Mihaela Aslan, Grant D. Huang, Kristina L. Bajema
Annals of Internal Medicine. 202348 CitationsOPEN ACCESS
Progression of intervention-focused research for Gulf War illness
Jeremy Chester, Mazhgan Rowneki, William Van Doren, Drew A. Helmer
S2739160569. 201941 CitationsOPEN ACCESS
Related on ScholarIQ
Office of Patient Care Services
Institution
Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes
Paper
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes
Paper
Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era
Paper
Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans
Paper
Progression of intervention-focused research for Gulf War illness
Paper